✦ LIBER ✦

Clinical and Experimental Aspects of Olmesartan Medoxomil, a New Angiotensin II Receptor Antagonist

✍ Scribed by Yoshida, Kazunori ;Kohzuki, Masahiro

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An angiotensin II type 1 receptor antago

✍ Nobuya Kurikawa; Miwa Suga; Shoko Kuroda; Keisuke Yamada; Hirokazu Ishikawa 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 325 KB

TCV-116: A New Angiotensin II Type-1 Rec

✍ Morimoto, Shigeto ;Ogihara, Toshio 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 695 KB

A Review of the Clinical Experience with

✍ Waeber, Bernard 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Hemodynamic and Clinical Effects of Angi

✍ Kenneth Dickstein 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 130 KB

Acidic phenols: a new class of potent no

✍ Dooseop Kim; Nathan B. Mantlo; J.R. Tata; K. Fitch; D. Dhanoa; K. Owens; D. Levo 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 388 KB

Efficient Synthesis of Valsartan, a Nonp

✍ Chen Zhang; Guojun Zheng; Lijing Fang; Yulin Li 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 9 KB 👁 1 views